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Background—Laryngopharyngeal reflux (LPR) can cause atypical symptoms, asthma, and
pulmonary fibrosis. The aim of this study was to establish the normative data for LPR using
hypopharyngeal multichannel intraluminal impedancepH (HMII).
Methods—Asymptomatic subjects underwent endoscopy followed by 24-h HMII using a
specialized impedance catheter configured to detect LPR before and after a 2-week course of
proton pump inhibitors (PPI). Subjects were excluded if they had esophageal pathology or a
positive DeMeester score. A cohort of 24 LPR patients who had a complete response to treatment
was used for comparison with the normative data.
Results—Forty subjects were enrolled. Thirty-four subjects completed one, and 25 completed
both HMII testing periods off and on PPI. There was no difference in the total number of reflux
events between off and on PPI [22 (8–32) and 24 (10–28), respectively, p=0.89]. The 95th
percentiles of LPR off and on PPI were 0 and 1, respectively. All patients with treatment
responsive LPR had pre-treatment HMII values of LPR greater than the 95th percentile.
Conclusion—LPR events are rare in an asymptomatic population. One or more LPR events
should be considered abnormal in patients with LPR symptoms regardless of whether there is a
positive DeMeester score.
Keywords
Laryngopharyngeal reflux; Hypopharyngeal multichannel intraluminal impedance-pH; Normative
data; Full column reflux
Introduction
The direct effects of refluxed gastric contents on the upper aerodigestive tract cause
laryngopharyngeal reflux (LPR), thus resulting in a different set of symptoms and clinical
course than those with typical gastroesophageal reflux disease (GERD). As few as three
episodes of laryngeal reflux per week can cause severe laryngeal inflammation and injury.1
In addition, reflux related distal esophageal injury can result in bronchoconstriction and
cough which are mediated by vagal afferent fibers.2 LPR is associated with atypical
symptoms such as chronic cough, hoarseness, throat clearing, sore throat, voice fatigue, and
globus sensation as well as pulmonary diseases such as asthma and pulmonary fibrosis.3
Persistent frequent exposure to the hypopharynx by gastric contents can lead to laryngeal
leukoplakia, laryngeal granulomata, and subglottic stenosis, and may serve as a co-factor in
the development of laryngeal cancer.4 Additionally, LPR is reported to have a more
significant impact on patients’ social functioning and vitality compared to typical GERD.5
The diagnosis of LPR has traditionally been made based on the presence of laryngeal
symptoms and laryngoscopic findings such as erythema, edema, ventricular obliteration,
postcricoid hyperplasia, and pseudosulcus.6 However, the sensitivity and specificity of these
laryngoscopic findings are poor, and they are identified in up to 86% of healthy
asymptomatic subjects.7 Dual-channel 24-h pH monitoring with esophageal and pharyngeal
pH probes has been shown to be effective to detect LPR.8,9 However, the pharyngeal pH
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probe is poorly sensitive secondary to the relatively alkaline environment within the
proximal aerodigestive tract; distal acid events become neutralized by saliva as they move
proximally from the stomach to the hypopharynx. In addition, this testing is limited to detect
acid LPR, not non-acid LPR which also has caustic properties. Based on this, the guideline
of the American College of Gastroenterology stated that “available evidence does not
support the routine use of proximal pH monitoring in clinical practice.”10 Therefore, there is
a need for more accurate, objective testing of LPR.
Multichannel intraluminal impedance combined with pH monitoring (MII-pH) has been
shown to be useful in patients with persistent symptoms despite acid suppression
therapy.11,12 MII-pH enables the detection and measurement of intraesophageal bolus
movement (regardless of pH) by detecting a change in resistance to current flow between
two electrodes when a liquid and/or gas bolus bridges them. When electrolyte-rich fluid is
present between the two impedance electrodes, impedance decreases due to the flow of
electrical current. In contrast, a gas event is poorly conductive and increases impedance.
Based on these differences in impedance characteristics, liquid, gas, and mixed liquid–gas
events can be differentiated. When multiple impedance electrode pairs are mounted on to the
same catheter, the direction and extent of bolus movement can be measured. An antegrade
(proximal to distal) progression of impedance changes represents swallowing, whereas a
retrograde (distal to proximal) progression represents a reflux event. Furthermore, the
catheter configuration can be tailored by changing the location of impedance electrodes and
pH probes, and this can be exploited to test for LPR.
We developed a specialized impedance catheter configured to detect proximal reflux events
such as LPR and full column reflux. The aim of this study was to establish the normative
data for LPR in an asymptomatic cohort using hypopharyngeal multichannel intraluminal
impedance-pH (HMII) and to determine if the normative data obtained can differentiate
patients with pathological LPR.
Materials and Methods
Study Design
This prospective trial was performed under the approval of institutional review board of the
University of Pittsburgh (PRO08070129). Subjects were recruited through community
advertising using popular media (news paper, flyers, word of mouth). Inclusion criteria
consisted of all asymptomatic subjects who were in good health and able to safely tolerate
unsedated transnasal endoscopy. Prior to enrollment, subjects completed a general medical
and social history questionnaire to rule out disorders of the upper gastrointestinal or
respiratory tracts. Absence of symptoms was confirmed by a score of zero on both the
GERD-HRQoL questionnaire13 and reflux symptom index.14 Exclusion criteria included
age <18 and >80 years, any past history of GERD (symptoms, medical treatment,
endoscopic findings, or antireflux surgery) and LPR symptoms such as globus sensation,
chronic cough, dysphonia, and throat clearing. Factors that potentially increased the risk of
transnasal endoscopy such as pregnancy, diverticulum, esophageal varices, and a history of
epistaxis were also considered exclusion criteria. All subjects underwent unsedated
transnasal endoscopy to exclude esophageal pathology such as esophagitis, hiatal hernia,
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Hill classification grade III or IV valve, inlet patch (ectopic gastric mucosa), and/or Barrett’s
esophagus. HMII-pH was then performed before and after a 2-week course of proton pump
inhibitors (PPI) (Omeprazole 20 mg, BID). Participants were instructed to take the
medication on an empty stomach, 30 min prior to a meal twice each day.15
Unsedated Transnasal Endoscopy
Subjects were fasted overnight prior to unsedated transnasal endoscopy. The subject was
placed in the sitting position and 7 ml of aerosolized 4% lidocaine was instilled using an
atomizer (Wolf Tory Medical, Salt Lake City, UT) into bilateral nares over a 5-min period.
A 4.7-mm-diameter flexible endoscope (TNE-5000, Vision-Sciences, Inc., Orangeburg,
NY), 65 cm in length, was placed inside a sterile sheath (EndoSheath®, Vision-Sciences,
Inc., Orangeburg, NY), which provided a durable, protective barrier as well as a coaxial 2.1
mm biopsy channel, and was then inserted transnasally into the most patent naris. The
mucosa of the nasopharynx, oropharynx, and hypopharynx was examined, and indirect
laryngoscopy was performed. With the neck in flexion, the endoscope was passed into the
esophagus in coordination with a swallow. The entire esophagus and proximal stomach were
examined to rule out mucosal and anatomic abnormalities. Retroflexion was performed to
evaluate the appearance of gastroesophageal valve; patients were excluded for a Hill
Classification grade III or IV valve.16 A solution of water and simethicone (Gold-line
Laboratories Inc., Miami, FL) was used to irrigate the field and obtain optimal exposure
during the procedure. The distance of the esophagogastric junction was measured and
recorded. We defined the location of anatomic esophagogastric junction as the distance in
centimeters from the naris to the most proximal termination of the gastric folds.
Hypopharyngeal Multichannel Intraluminal Impedance Combined with pH Monitoring
(HMII-pH)
A specialized, bifurcated impedance catheter with a 2.3 mm of outer diameter configured to
detect both acid and non-acid LPR (CZAI-B62C47E) (Sandhill Scientific, Inc., Highlands
Ranch, CO) was fabricated and employed in this study (Fig. 1). The long arm branch of the
catheter had two electrode pairs positioned at 3 and 5 cm proximal to the esophagogastric
junction with the pH sensor positioned 5 cm proximal to the junction. The short arm branch
had two electrode pairs each in the proximal esophagus and the hypopharynx with the
second pH sensor located 0.5 cm proximal to the upper border of the cricopharyngeus
muscle.
The impedance catheter was calibrated immediately prior to placement using reference
solutions (Sandhill Scientific, Inc., Highlands Ranch, CO). An external reference electrode
was attached to the anterior chest wall over the mid-sternum. After the location of the
esophagogastric junction was endoscopically measured, the long branch of catheter was
placed transnasally such that the esophageal pH sensor was located 5 cm proximal to the
esophagogastric junction. The short branch of the catheter was then placed through the same
naris under endoscopic guidance, and the blue visual positioning band was placed at the
upper border of the cricopharyngeus muscle. The positions (in centimeters) of both catheter
branches were recorded so that the second “on PPI” HMII-pH catheter placement could be
performed without endoscopic guidance. The catheter was secured on to the participant’s
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face and neck with a transparent adhesive covering (3M, St. Paul, MN) in order to avoid
displacement. The catheter was attached to an ambulatory recording device, and the total
testing period was 24 h in length. Subjects were encouraged to attempt to maintain their
usual activities, sleep schedule, and eating habits during the testing period. Subjects were
instructed on how to record meal times and body position (supine, upright) changes.
Test Interpretation and Reflux Definitions
Data were transferred and analyzed using dedicated software (Bioview Analysis™, Sandhill
Scientific Inc., Highlands Ranch, CO). A retrograde 50% fall in impedance from the mean
baseline impedance between the two electrode pairs indicated the presence of liquid-only
reflux. The mean was calculated from baseline impedance values measured 5 s prior to the
decrease. Gas reflux was defined as an abrupt increase in impedance >3,000 Ω in any two
consecutive impedance sites with one site having an absolute value >7,000 Ω. Mixed liquid–
gas reflux was defined as an abrupt increase in impedance (gas) occurring during or
immediately before liquid reflux. LPR events were considered present with retrograde bolus
transit across all ring sets that ultimately reached the hypopharynx (Fig. 2). In addition to
this impedance finding, LPR was categorized into three groups based on pH in esophagus
and hypopharynx: (1) acid LPR when both pH were <4, (2) non-acid LPR when both pH
were >4, and (3) acid to nonacid LPR when esophageal pH was <4 but pharyngeal pH was
>4. Full column reflux was defined as reflux that reached the impedance site 2 cm distal to
the cricopharyngeus muscle but did not reach the hypopharyngeal ring set. Acid exposure
time (percent) was defined as the total time pH <4 divided by the time monitored.
DeMeester score was calculated for the distal pH monitor using established criteria.17 Meal
times were excluded from analysis. All tracings were individually reviewed to determine the
type of reflux events and the proximal extent as measured by impedance and pH.
Comparison with “True LPR” Patients
For comparison with the normative data, a cohort of patients was selected based on the
presence of pre-treatment confirmed LPR and atypical symptoms and a subsequent complete
response to medical or surgical therapy. From October 2009 to October 2010, 202 patients
with GERD and/or LPR symptoms underwent HMII-pH using the same catheter
configuration as in the asymptomatic cohort. Eighteen patients were excluded because of
sensor noise. All tracings were analyzed in an identical manner as outlined for the
asymptomatic cohort. Of 184, 38 patients (20.7%) had one or more LPR events detected
during 24-h HMII-pH. Of 38, 24 patients had pre-treatment documented LPR (≥1 event
detected by HMII-pH with the same catheter configuration) with LPR predominate
symptoms (LPR symptoms alone or LPR symptoms coupled with heartburn and/or
regurgitation). Of them, 10 patients had a complete response with PPI therapy and 14
patients had symptom resolution with antireflux surgery after an incomplete response to
medical therapy. Post-operative symptoms were assessed based on personal interview at 6
weeks and 1 year after initiating therapy. As part of an on-going quality assurance initiative,
patients are contacted at these intervals and asked symptom resolution and satisfaction to
treatment. A “complete response” was considered achieved when pre-treatment symptoms
were completely resolved with good patients’ satisfaction to treatment. A large number of
these patients had pre-treatment esophagitis or hiatal hernia (Table 1).
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Values were expressed as median, interquartile range, and 95th percentile values. The 95th
percentile of each type of reflux event was calculated using a Poisson distribution. The 95th
percentile values represent the upper limit of normative data for 24-h HMII-pH and were
used as cut-off points between normal vs. abnormal. Because experimental data were not
normally distributed, statistical analysis was performed by means of the non-parametric




From a total of 75 subjects who responded to the advertisements, 40 subjects (18 male, 22
female) were enrolled in this study. Mean age and body mass index were 33 years (range,
19–59 years) and 26.1 (range, 17.5–40), respectively. All 40 subjects underwent unsedated
transnasal endoscopy followed by HMII-pH off PPI. Six subjects were excluded because of
a positive DeMeester score (n=3) or improper recording such as sensor noise and short
duration of study (n=3). These three subjects with a positive DeMeester score were
excluded. Following a 2-week course of PPI, 33 subjects underwent the second HMII-pH on
PPI. Five subjects were excluded because of improper recording. As a result, complete data
sets were available for 34 and 25 subjects off and on PPI, respectively (Fig. 3).
LPR and Full Column Events in Normal Subjects
One of the 34 subjects who completed HMII off PPI had 1 LPR event, and 2 of 25 subjects
who completed HMII on PPI had 1 and 3 LPR events, respectively. Based on the 95th
percentile values, the normal values of LPR off and on PPI were 0 and 1, respectively. The
normal value of full column reflux (2 cm distal to the cricopharyngeus muscle) was 4 for
both off and on PPI. There was no significant difference in the total number of reflux events
between off and on PPI (median, 22 and 24, respectively; p=0.89). The 95th percentile
values of total reflux events (any reflux into the esophagus) off and on PPI were 48 and 40,
respectively. Most hypopharyngeal acid exposure off and on PPI occurred in the upright
position (median, 0.9 and 0.5, respectively) compared to the supine position (median, both
0). Of total reflux events, 87.4% off PPI and 80% on PPI occurred in the upright position.
The values in each component of acid exposure time between off and on PPI were not
significantly different (Table 2).
Composition and Patterns of Proximal Reflux Events
We defined proximal exposure as LPR combined with full column reflux. Of total reflux
events into the esophagus, proximal exposure was 7% in normal subjects both off and on
PPI, compared to greater than 50% in LPR patients, even though there was no significant
difference in the total number of reflux events between groups (Table 3). Although most of
LPR events in normal subjects were acid, nearly 40% of LPR events in LPR patients were
non-acid in the hypopharynx. Thirty percent of LPR events in LPR patients were acid in the
distal esophagus but turned non-acid in the hypopharynx. In terms of composition, most of
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LPR events in normal subjects were liquid, whereas half of LPR events in LPR patients
were mixed (liquid and gas). On the other hand, there was essentially no difference in
composition of full column reflux between normal subjects and LPR patients, a half of
which were mixed (Table 4).
Comparison of LPR Patients with the Normative Data
The HMII values of LPR and full column reflux events in LPR patients were significantly
greater than those in normal subjects despite no significant difference in the total number of
reflux events between groups (Table. 5). In particular, there was no overlap of LPR values
between groups (Fig. 4). The majority of proximal events such as LPR and full column
reflux occurred in the upright position in both groups. Although DeMeester score in LPR
patients was significantly higher than in normal subjects, a large number of LPR patients
had a negative DeMeester score, which may reflect the fact that there was no significant
difference in the total number of reflux events between groups.
Discussion
LPR symptoms have been recognized as a common entity, affecting an estimated 20% of the
adult population in the USA.18 However, laryngeal symptoms are non-specific and can be
associated with smoking, toxic inhalants, environmental allergies, and postnasal discharge
with or without any defined organic origin.19 As an initial diagnostic measure, it is currently
recommended that patients be started on an empiric 3-month trial of high-dose PPI.19
However, PPI therapy is associated with a significant placebo effect and most controlled
trials have failed to demonstrate any benefit in patients with suspected LPR related laryngeal
symptoms.20,21 Two recent meta-analysis have demonstrated the absence of therapeutic
benefit of PPIs in this setting.22,23 Similarly, the outcomes of surgical fundoplication in
patients with laryngeal symptoms have been less effective than for patients with typical
symptoms of GERD.24–28
Previous studies have suggested that a direct measure of LPR will be essential to guide
treatment in LPR patients and that this will ultimately lead to improved outcomes. A “pH-
centric” focus and lack of symptom correlation in the setting of LPR are important factors
that contribute to the low sensitivity and specificity of currently available testing modalities.
It is important to consider that LPR symptoms may be caused by direct gastric fluid
exposure to the hypopharynx (direct mechanism) or vagal-mediated bronchoconstriction due
to gastric fluid exposure to the distal esophagus (indirect mechanism),2 and a symptom
index is therefore difficult to interpret and depend upon in establishing a diagnosis.
Furthermore, LPR events appear to be rare even in patients with “true LPR” and therefore a
composite scoring system for LPR (similar to the DeMeester score used for GERD) may
therefore be difficult to establish. Finally, as demonstrated in the present study, a majority of
LPR events are either non-acid or weakly acid and would not be detected with
extraesophageal pH monitoring configurations.
Several studies have demonstrated the usefulness of MII-pH to evaluate patients with
LPR24,29,30 and that the proximal extent of reflux, rather than non-acid reflux, may play a
more important role in the development laryngeal symptoms.29 The impedance catheter used
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in previous studies had impedance electrode pairs and pH probes only in the esophagus
(distal and proximal), not in the hypopharynx. These catheters were therefore not optimized
to directly measure LPR. A limitation to the implementation of hypopharyngeal impedance
testing has been related to excessive noise secondary to air exposure and swallowing over
the paired electrodes. Oelschlager et al. utilized a specially designed bifurcated impedance
catheter, in which one branch had four impedance electrode pairs (3, 5, 7, and 9 cm above
the gastroesophageal junction (GEJ)) and esophageal pH probe (5 cm above the GEJ), and
the other branch had a pharyngeal pH sensor (2 cm) above the upper esophageal sphincter
(UES) and a pair of impedance electrodes below (5 cm) and above (2 cm) the UES.31 The
results of MII-pH with this catheter on ten healthy subjects showed that the median number
of pharyngeal reflux was 5, which is higher than the number observed in the present study.
This catheter had only one pair of electrodes in the hypopharynx, and it may have been
difficult to differentiate pharyngeal reflux from the initiation of a swallow. In contrast, the
catheter used in the present study had two pairs of impedance electrodes each in the distal
and proximal esophagus as well as the hypopharynx. Therefore, antegrade versus retrograde
bolus movement could be effectively differentiated and LPR confirmed as retrograde bolus
transit “tracked” along the entire esophagus and into the hypopharynx. The modifications
that enabled extraesophageal impedance measurements to be obtained in this study included
close spacing of electrode pairs adjacent to the pH probe and placement of the electrodes
immediately proximal to the upper border of the cricopharyngeus muscle. This catheter
configuration and placement technique was achieved by trial and error in pilot work until
proximal noise was eliminated.
Although there are studies demonstrating normal values for 24-h MII-pH off PPI,32–35 this
is the first report to provide the normative data of each reflux event for 24-h HMII-pH both
off and on PPI in the same individual. Since empiric PPI therapy has been commonly used
in patients with possible LPR, we desired to assess the effect of PPI on the patterns of reflux
in the context of this novel catheter. Our results indicate that there was a trend towards more
LPR events seen on PPI than off PPI (0 off PPI vs. 1 on PPI) despite no significant
difference in the total number of reflux events between off and on PPI. The reason for this
remains unclear. On the other hand, “full column reflux” is a different entity than “proximal
reflux” reported previously. Conventional “proximal reflux” has been defined as reflux that
reaches 15 cm above the LES, whereas “full column reflux” is define as reflux that reaches
the impedance site 2 cm below the UES. In a previous multicenter trial to determine
normative data for 24-h MII-pH,32 Shay et al. demonstrated that the normal value of
conventional “proximal reflux” is 31 events. Our result indicates that “full column reflux” is
a much rarer event compared to conventional “proximal reflux” (normal value, 4 vs. 31,
respectively). Interestingly, approximately 45% of total reflux events were full column
reflux in patients with treatment responsive LPR. The number of full column reflux events
may potentially be used as a predictor of pathological LPR.
Given the fact that a large number of patients with treatment responsive LPR had a negative
DeMeester score as well as an abnormal number of total reflux events implies that
traditional pH testing would not be sensitive enough to make the diagnosis of LPR in these
patients. In addition, nearly 40% of LPR events were non-acid in the hypopharynx and
therefore these events would not be detected by conventional dual-channel pH monitoring.
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Recently, the Restech pH catheter (Respiratory Technology Corp., San Diego, CA) has been
reported to be a sensitive and minimally invasive device for detection of acid reflux in the
posterior orophayrnx.36 However, it should be noted that a substantial number of LPR
events are non-acid in the oropharynx, and this technique may therefore underestimate the
disease. In contrast, the impedance catheter used in the present study successfully detected
all forms of LPR. All patients with treatment responsive LPR had a pre-treatment HMII
value of LPR greater than the 95th percentile value of LPR in normal subjects. This
indicates that the specificity of HMII with this catheter is very high. However, the sensitivity
of this catheter is unknown because there has been no way to detect “true LPR” other than
our system and a false-negative rate cannot be determined.
In conclusion, HMII-pH appears to be an extremely promising test to objectively measure
events of LPR. This study establishes the normative data for LPR using HMII-pH with a
specialized impedance catheter. LPR events are extremely rare in patients without GERD or
LPR symptoms as measured with HMII-pH. One or more LPR events should be considered




Dr. John F. Sweeney (Atlanta, GA): Good morning and Happy Mother’s Day. My name is
John Sweeney and I am Chief of General and Gastrointestinal Surgery at Emory University
in Atlanta. I would like to take the opportunity to thank the Society for the opportunity to
discuss this manuscript. Before I begin, I would like to congratulate Dr. Hoppo on a fine
presentation. In addition I would like to thank the authors for providing me a copy of their
manuscript for review well in advance of the meeting. It is clearly and concisely written. I
have three questions:
1. The manuscript states that healthy subjects were recruited through community
advertising. How did you incentivize their participation? Were they paid? If so,
when did this occur? After each completed test? At the end of the entire
experiment? What happened if they completed the tests but the data were not felt to
be usable? Were they still paid?
2. The next question is regarding the LPR treatment responsive group. The
manuscript states that subjects were selected from a group of patients with atypical
symptoms of LPR that had a complete response to medical or surgical therapy.
Were there any differences in impedance results for each subgroup of patients?
3. As you clearly state in the discussion of your manuscript, the outcomes for either
medical or surgical management of LPR can vary significantly. How will the
results of this study lead to better stratification of patients with LPR to the modality
that they are most likely to respond? More importantly, do you envision that this
modality will help us identify patients that will not respond to a fundoplication and
therefore in whom surgery should therefore be avoided?
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Again, I would like to thank the Society for the privilege of discussing this paper and
congratulate the authors on a well-designed and well-executed study.
Closing Discussant
Dr. Toshitaka Hoppo: Thank you very much for your great comments and questions, Dr.
Sweeney.
1. The first question was regarding incentive for participants. All participants were
paid twice after each impedance testing. They were paid $125 after the placement
of the first impedance catheter and $75 after the placement of the second
impedance catheter. They were still paid if the data were not usable.
2. The second question was regarding difference in LPR events in patients who
responded to medical therapy and surgical therapy. When looked at the difference
in the number of LPR events on impedance testing, there was a trend towards more
LPR events observed in surgical therapy responsive patients compared to medical
therapy responsive patients (3 vs. 1.2/day). This may be explained by that more
LPR events cannot be controlled well by medical therapy.
3. The last question was regarding the stratification with impedance testing. This is a
good question. It is important to determine who would benefit from the treatment
and what treatment would be the best. The impedance testing can make a diagnosis
of LPR but cannot tell us what the best treatment would be for each patient.
However, making an accurate diagnosis of LPR should contribute to the better
outcomes of treatments.
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A specialized, bifurcated impedance catheter configured to detect LPR. The long arm branch
of the catheter had two electrode pairs positioned at 3 and 5 cm proximal to the
esophagogastric junction with the pH sensor positioned 5 cm proximal to the junction. The
short arm branch had two electrode pairs each in the proximal esophagus and the
hypopharynx with the second pH sensor located 0.5 cm proximal to the cricopharyngeus
muscle
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Impedance tracing of acid LPR. Acid LPR is defined when retrograde bolus transit occurs
across all ring sets and ultimately reaches the hypopharynx in addition to both esophageal
and pharyngeal pH sensors dropping <4
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Flow chart of study subjects. From a total of 75 subjects who responded to the
advertisements, 40 subjects were enrolled. Forty subjects underwent HMII off PPI and 33 on
PPI. Complete data sets were available for final analysis in 34 subjects off PPI and 25
subjects on PPI
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Normal subjects (off PPI) vs. treatment responsive LPR patients (off PPI). All patients with
treatment responsive LPR had pre-treatment HMII values greater than the 95th percentile
values of normal subjects in all criteria except total number of reflux events
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Table 1
Demographics of healthy volunteer (n=40) and LPR patients (n=24)
Healthy volunteer (n=40) Treatment responsive LPR patients (n=24)
Sex M=18, F=22 M=6, F=18
Age (years) 33 (range, 19–59) 55 (range, 29–78)
BMI (kg m−2) 26.1 (range, 17.5–40) 28.4 (range, 19.1–43.8)
Race Caucasian (28), African-American (7), Asian (2), Hispanic (3) Caucasian (23), African-American (1)
Esophagitis 0 75% (10/15)
Hiatal hernia 0 81.3% (13/16)
Complete response to therapy n/a PPI (10), ARS (14)
PPI proton pump inhibitor; ARS antireflux surgery
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Table 3
The proportion of proximal reflux events such as LPR and full column reflux
Off PPI (n=34) On PPI (n=25) Treatment responsive LPR patients (n=24)
LPR 0.14% (1/705) 0.74% (4/542) 9.3% (55/590)
Full column reflux 6.8% (48/705) 6.5% (35/542) 43.4% (256/590)
Total reflux events (mean±SD) 20.7±14.5 21.7±14.3 24.5±14.5
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Table 5
Normal subjects (off PPI) vs. treatment responsive LPR patients (off PPI)
HMII measurements Normal subjects
(off PPI): N=34
Treatment responsive LPR patients
(off PPI): N=24
p value
Number of LPR events 0 (0–0) 1 (1–2) <0.001
Number of full column reflux events (2 cm distal to UES) 1 (0–2.75) 9.5 (5.8–17) <0.001
Number of total reflux events 22 (8.3–32) 23.5 (12.8–32.5) 0.301
DMS 3.1 (1.2–5.4) 8.2 (5.0–16.8) <0.001
Predominate position of events Upright Upright
Values are expressed as a median (interquartile range). Variables were compared using the non-parametric Wilcoxon signed rank test and a p
value<0.05 was considered significant
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